In this video, I go through Sangamo’s updated data with their Hemophilia A and Beta-Thalassemia treatments. I also talk about Viking Therapeutics’ VK5211, a potent selective androgen receptor modulator.

Follow me @matthewlepoire

*This is not investment advice*

http://www.breakingbiotech.com

#breakingbiotech #SGMO #VKTX